| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 36,130,000 | 45,203,000 | 78,867,000 | 82,989,000 | | Cost of Revenue | 25,127,000 | 29,329,000 | 55,185,000 | 61,611,000 | | | Gross Profit | 11,003,000 | 15,874,000 | 23,682,000 | 21,378,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,955,000 | 6,039,000 | 6,892,000 | 7,338,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,867,000 | 2,589,000 | 2,449,000 | 2,275,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,181,000 | 7,246,000 | 14,341,000 | 11,765,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,181,000 | 7,240,000 | 14,309,000 | 11,731,000 | | Interest Expense | 8,000 |
-
|
-
|
-
| | Income Before Tax | 3,173,000 | 7,240,000 | 14,309,000 | 11,731,000 | | Income Tax Expense | 1,319,000 | 2,345,000 | 6,416,000 | 5,756,000 | | Minority Interest | (17,000) | (6,000) | (32,000) | (34,000) | | | | Net Income From Continuing Ops | 1,837,000 | 4,895,000 | 7,893,000 | 5,975,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,837,000 | 4,895,000 | 7,893,000 | 5,975,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,837,000 | $4,895,000 | $7,893,000 | $5,975,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
